Press Release: Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians evaluate and discuss early signs of progression to secondary progressive MS

• Published in: Dow Jones Institutional News
• Format: Newsletter
• Language: English
• Published: New York Dow Jones & Company Inc 07.05.2019
• Subjects: Algorithms; Alzheimer's disease; Clinical medicine; Multiple sclerosis; Neurosciences; Patients; Physicians; Qualitative research; R&D; Research & development; Social networks; Validation studies; Canada; United States > US; Germany; Pennsylvania